Design and Synthesis of Novel Hybrid Molecules against Malaria

  • Lödige M
  • Hiersch L
Citations of this article
Mendeley users who have this article in their library.


The effective treatment of malaria can be very complex: Plasmodium parasites develop in multiple stages within a complex life cycle between mosquitoes as vectors and vertebrates as hosts. For the full and effective elimination of parasites, an effective drug should be active against the earliest stages of the Plasmodium infection: liver stages (reduce the progress of the infection), blood stages (cure the clinical symptoms), and gametocytes (inhibit the transmission cycle). Towards this goal, here we report the design, the synthetic methodology, and the characterization of novel hybrid agents with combined activity against Plasmodium liver stages and blood stages and gametocytes. The divergent synthetic approach allows the access to differently linked primaquine-chloroquine hybrid templates in up to eight steps.




Lödige, M., & Hiersch, L. (2015). Design and Synthesis of Novel Hybrid Molecules against Malaria. International Journal of Medicinal Chemistry, 2015, 1–23.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free